|
2025-04-18 |
2025-04-17 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
1 000
+0.3%
11,52
630 819 USD
|
1 000
+0.3%
|
11,52
|
100 000 USD
|
|
|
2025-04-18 |
2025-04-16 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
1 000
+0.4%
11,16
825 589 USD
|
1 000
+0.4%
|
11,16
|
100 000 USD
|
|
|
2025-04-07 |
2025-04-04 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
196 438
+1.1%
11,17
2 193 800 USD
|
196 438
+1.1%
|
11,17
|
2 193 800 USD
|
|
|
2025-04-07 |
2025-04-03 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
120 770
+0.7%
11,84
1 430 170 USD
|
120 770
+0.7%
|
11,84
|
1 430 170 USD
|
|
|
2025-04-02 |
2025-04-02 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
74 360
+0.4%
11,85
881 017 USD
|
74 360
+0.4%
|
11,85
|
881 017 USD
|
|
|
2025-04-02 |
2025-04-01 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
48 658
+0.3%
11,60
564 647 USD
|
48 658
+0.3%
|
11,60
|
564 647 USD
|
|
|
2025-04-02 |
2025-03-31 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
4 397
+0.0%
11,75
51 658 USD
|
4 397
+0.0%
|
11,75
|
51 658 USD
|
|
|
2025-03-27 |
2025-03-26 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
43 848
+0.3%
12,24
536 857 USD
|
43 848
+0.3%
|
12,24
|
536 857 USD
|
|
|
2025-03-27 |
2025-03-25 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
53 501
+0.3%
12,91
690 452 USD
|
53 501
+0.3%
|
12,91
|
690 452 USD
|
|
|
2025-03-24 |
2025-03-24 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
22 689
+0.1%
13,08
296 847 USD
|
22 689
+0.1%
|
13,08
|
296 847 USD
|
|
|
2025-03-24 |
2025-03-21 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
31 033
+0.2%
12,78
396 518 USD
|
31 033
+0.2%
|
12,78
|
396 518 USD
|
|
|
2025-03-24 |
2025-03-20 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
73 476
+0.4%
12,93
949 883 USD
|
73 476
+0.4%
|
12,93
|
949 883 USD
|
|
|
2025-03-19 |
2025-03-19 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
58 306
+0.3%
12,64
737 233 USD
|
58 306
+0.3%
|
12,64
|
737 233 USD
|
|
|
2025-03-19 |
2025-03-18 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
113 880
+0.7%
12,65
1 440 855 USD
|
113 880
+0.7%
|
12,65
|
1 440 855 USD
|
|
|
2025-03-19 |
2025-03-17 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
56 277
+0.3%
12,23
688 465 USD
|
56 277
+0.3%
|
12,23
|
688 465 USD
|
|
|
2025-03-13 |
2025-03-13 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
468 356
+2.9%
12,48
5 847 237 USD
|
468 356
+2.9%
|
12,48
|
5 847 237 USD
|
|
|
2025-03-13 |
2025-03-12 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
292 934
+1.8%
12,25
3 587 826 USD
|
292 934
+1.8%
|
12,25
|
3 587 826 USD
|
|
|
2025-03-13 |
2025-03-11 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
320 690
+2.0%
11,49
3 685 851 USD
|
320 690
+2.0%
|
11,49
|
3 685 851 USD
|
|
|
2025-01-21 |
2025-01-17 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
19 748
+0.1%
13,87
273 998 USD
|
19 748
+0.1%
|
13,87
|
273 998 USD
|
|
|
2025-01-21 |
2025-01-16 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
121 681
+0.8%
13,89
1 689 541 USD
|
121 681
+0.8%
|
13,89
|
1 689 541 USD
|
|
|
2025-01-15 |
2025-01-15 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
39 029
+0.3%
14,01
546 671 USD
|
39 029
+0.3%
|
14,01
|
546 671 USD
|
|
|
2025-01-15 |
2025-01-14 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
54 500
+0.4%
13,56
739 265 USD
|
54 500
+0.4%
|
13,56
|
739 265 USD
|
|
|
2025-01-15 |
2025-01-13 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
74 125
+0.5%
13,39
992 875 USD
|
74 125
+0.5%
|
13,39
|
992 875 USD
|
|
|
2025-01-10 |
2025-01-10 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
204 098
+1.3%
13,13
2 678 990 USD
|
204 098
+1.3%
|
13,13
|
2 678 990 USD
|
|
|
2025-01-10 |
2025-01-08 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
21 021
+0.1%
14,07
295 829 USD
|
21 021
+0.1%
|
14,07
|
295 829 USD
|
|
|
2025-01-06 |
2025-01-06 |
V
Vente
|
Moore Paul Andrew
Chief Scientific Officer
Dirigeant
|
11 408
-32.8%
14,92
170 254 USD
|
11 408
-32.8%
|
14,92
|
170 254 USD
|
|
|
2025-01-06 |
2025-01-06 |
V
Vente
|
Moore Paul Andrew
Chief Scientific Officer
Dirigeant
|
9 792
-39.9%
14,92
146 137 USD
|
9 792
-39.9%
|
14,92
|
146 137 USD
|
|
|
2025-01-06 |
2025-01-06 |
V
Vente
|
Galbraith Kenneth
Chair & CEO
Administrateur exécutif
|
33 406
-29.2%
14,92
498 554 USD
|
33 406
-29.2%
|
14,92
|
498 554 USD
|
|
|
2025-01-06 |
2025-01-06 |
V
Vente
|
Galbraith Kenneth
Chair & CEO
Administrateur exécutif
|
23 885
-33.4%
14,92
356 462 USD
|
23 885
-33.4%
|
14,92
|
356 462 USD
|
|
|
2025-01-06 |
2025-01-06 |
V
Vente
|
Smith Jeffrey T L
EVP & Chief Medical Officer
Dirigeant
|
11 110
-55.5%
14,92
165 807 USD
|
11 110
-55.5%
|
14,92
|
165 807 USD
|
|
|
2025-01-02 |
2025-01-02 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
157 880
+1.1%
14,78
2 333 403 USD
|
157 880
+1.1%
|
14,78
|
2 333 403 USD
|
|
|
2025-01-02 |
2024-12-31 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
146 501
+1.0%
14,57
2 134 446 USD
|
146 501
+1.0%
|
14,57
|
2 134 446 USD
|
|
|
2025-01-02 |
2024-12-30 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
58 988
+0.4%
14,47
853 326 USD
|
58 988
+0.4%
|
14,47
|
853 326 USD
|
|
|
2024-12-27 |
2024-12-27 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
101 659
+0.7%
14,49
1 473 181 USD
|
101 659
+0.7%
|
14,49
|
1 473 181 USD
|
|
|
2024-12-27 |
2024-12-26 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
16 692
+0.1%
14,38
240 038 USD
|
16 692
+0.1%
|
14,38
|
240 038 USD
|
|
|
2024-12-27 |
2024-12-24 |
A
Achat
|
EcoR1 Capital, LLC
Administrateur non-exécutif
Actionnaire important
|
11 958
+0.1%
14,12
168 896 USD
|
11 958
+0.1%
|
14,12
|
168 896 USD
|
|
|
2024-01-08 |
2024-01-08 |
V
Vente
|
Astle Christopher
SVP & Chief Financial Officer
Dirigeant
|
1 431
-18.0%
11,22
16 050 USD
|
1 431
-18.0%
|
11,22
|
16 050 USD
|
|
|
2024-01-08 |
2024-01-08 |
V
Vente
|
Galbraith Kenneth
Chair & CEO
Administrateur exécutif
|
5 706
-19.4%
11,22
63 996 USD
|
5 706
-19.4%
|
11,22
|
63 996 USD
|
|
|
2024-01-08 |
2024-01-08 |
V
Vente
|
Moore Paul Andrew
Chief Scientific Officer
Dirigeant
|
2 339
-24.1%
11,22
26 233 USD
|
2 339
-24.1%
|
11,22
|
26 233 USD
|
|
|
2024-01-08 |
2024-01-05 |
V
Vente
|
Astle Christopher
SVP & Chief Financial Officer
Dirigeant
|
4 563
-36.5%
10,65
48 606 USD
|
4 563
-36.5%
|
10,65
|
48 606 USD
|
|
|
2024-01-08 |
2024-01-05 |
V
Vente
|
Galbraith Kenneth
Chair & CEO
Administrateur exécutif
|
18 198
-38.2%
10,65
193 849 USD
|
18 198
-38.2%
|
10,65
|
193 849 USD
|
|
|
2024-01-08 |
2024-01-05 |
V
Vente
|
Moore Paul Andrew
Chief Scientific Officer
Dirigeant
|
7 460
-43.5%
10,65
79 465 USD
|
7 460
-43.5%
|
10,65
|
79 465 USD
|
|
|
2023-12-11 |
2023-12-11 |
V
Vente
|
Astle Christopher
SVP & Chief Financial Officer
Dirigeant
|
886
-30.7%
9,13
8 089 USD
|
886
-30.7%
|
9,13
|
8 089 USD
|
|
|
2023-06-21 |
2023-06-16 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
3 350 000
+33.2%
8,12
27 202 000 USD
|
3 350 000
+33.2%
|
8,12
|
27 202 000 USD
|
|
|
2023-03-30 |
2023-03-28 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
200 000
+2.0%
8,00
1 600 000 USD
|
200 000
+2.0%
|
8,00
|
1 600 000 USD
|
|
|
2023-03-14 |
2023-03-10 |
V
Vente
|
Klompas Neil A
President & COO
Dirigeant
|
2 977
-14.9%
7,83
23 298 USD
|
2 977
-14.9%
|
7,83
|
23 298 USD
|
|
|
2023-01-23 |
2023-01-20 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
163 400
+1.7%
9,88
1 615 095 USD
|
163 400
+1.7%
|
9,88
|
1 615 095 USD
|
|
|
2023-01-23 |
2023-01-19 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
144 100
+1.5%
9,49
1 367 639 USD
|
144 100
+1.5%
|
9,49
|
1 367 639 USD
|
|
|
2023-01-18 |
2023-01-18 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
203 000
+2.2%
10,00
2 029 046 USD
|
203 000
+2.2%
|
10,00
|
2 029 046 USD
|
|
|
2023-01-18 |
2023-01-17 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
440 000
+4.9%
9,80
4 313 848 USD
|
440 000
+4.9%
|
9,80
|
4 313 848 USD
|
|
|
2023-01-18 |
2023-01-13 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
342 100
+4.0%
9,81
3 354 633 USD
|
342 100
+4.0%
|
9,81
|
3 354 633 USD
|
|
|
2023-01-12 |
2023-01-11 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
106 300
+1.3%
7,87
836 911 USD
|
106 300
+1.3%
|
7,87
|
836 911 USD
|
|
|
2023-01-12 |
2023-01-10 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
920 000
+12.2%
7,65
7 037 172 USD
|
920 000
+12.2%
|
7,65
|
7 037 172 USD
|
|
|
2022-12-14 |
2022-12-12 |
VP
Vente planifiée
|
Astle Christopher
SVP & Chief Financial Officer
Dirigeant
|
887
-40.0%
6,01
5 331 USD
|
887
-40.0%
|
6,01
|
5 331 USD
|
|
|
2022-11-14 |
2022-11-10 |
VP
Vente planifiée
|
Josephson Neil
Chief Medical Officer
Dirigeant
|
2 475
-14.6%
8,10
20 045 USD
|
2 475
-14.6%
|
8,10
|
20 045 USD
|
|
|
2022-11-14 |
2022-11-10 |
VP
Vente planifiée
|
Josephson Neil
Chief Medical Officer
Dirigeant
|
2 475
-14.6%
8,10
20 045 USD
|
2 475
-14.6%
|
8,10
|
20 045 USD
|
|
|
2022-03-11 |
2022-03-10 |
VP
Vente planifiée
|
Klompas Neil A
Chief Operating Officer
Dirigeant
|
2 979
-18.3%
6,88
20 496 USD
|
2 979
-18.3%
|
6,88
|
20 496 USD
|
|
|
2022-01-11 |
2022-01-07 |
A
Achat
|
Josephson Neil
Chief Medical Officer
Dirigeant
|
3 600
+102.3%
14,28
51 408 USD
|
3 600
+102.3%
|
14,28
|
51 408 USD
|
|
|
2022-01-11 |
2022-01-07 |
A
Achat
|
Josephson Neil
Chief Medical Officer
Dirigeant
|
1 400
+66.1%
14,27
19 978 USD
|
1 400
+66.1%
|
14,27
|
19 978 USD
|
|
|
2021-04-13 |
2021-04-13 |
VP
Vente planifiée
|
Priour James
Chief Commercial Officer
Dirigeant
|
950
-32.2%
27,93
26 533 USD
|
950
-32.2%
|
27,93
|
26 533 USD
|
|
|
2021-03-17 |
2021-03-15 |
V
Vente
|
O'Driscoll Kathryn
Chief People Officer
Dirigeant
|
786
-13.6%
34,72
27 290 USD
|
786
-13.6%
|
34,72
|
27 290 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
O'Driscoll Kathryn
Chief People Officer
Dirigeant
|
568
-8.9%
34,95
19 854 USD
|
568
-8.9%
|
34,95
|
19 854 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
Tehrani Ali
Chief Executive Officer
Administrateur exécutif
|
4 392
-1.7%
34,95
153 516 USD
|
4 392
-1.7%
|
34,95
|
153 516 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
1 048
-16.3%
34,95
36 631 USD
|
1 048
-16.3%
|
34,95
|
36 631 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
Polverino Anthony J.
Chief Scientific Officer
Dirigeant
|
1 048
-3.3%
34,95
36 631 USD
|
1 048
-3.3%
|
34,95
|
36 631 USD
|
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
Klompas Neil A
Chief Financial Officer
Dirigeant
|
1 425
-12.0%
34,95
49 809 USD
|
1 425
-12.0%
|
34,95
|
49 809 USD
|
|
|
2020-12-11 |
2020-12-09 |
V
Vente
|
Klompas Neil A
Chief Financial Officer
Dirigeant
|
25 000
-73.3%
53,25
1 331 133 USD
|
25 000
-73.3%
|
53,25
|
1 331 133 USD
|
|
|
2020-12-09 |
2020-12-07 |
V
Vente
|
Tehrani Ali
Chief Executive Officer
Administrateur exécutif
|
850
-1.5%
56,16
47 736 USD
|
850
-1.5%
|
56,16
|
47 736 USD
|
|
|
2020-12-04 |
2020-12-04 |
VP
Vente planifiée
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
6 032
-61.9%
55,12
332 476 USD
|
6 032
-61.9%
|
55,12
|
332 476 USD
|
|
|
2020-12-03 |
2020-12-02 |
VP
Vente planifiée
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
701
-15.9%
55,01
38 563 USD
|
701
-15.9%
|
55,01
|
38 563 USD
|
|
|
2020-12-03 |
2020-12-01 |
VP
Vente planifiée
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
18 267
-83.1%
55,19
1 008 240 USD
|
18 267
-83.1%
|
55,19
|
1 008 240 USD
|
|
|
2020-11-04 |
2020-11-02 |
V
Vente
|
Tehrani Ali
Chief Executive Officer
Administrateur exécutif
|
3 500
-5.8%
39,04
136 624 USD
|
3 500
-5.8%
|
39,04
|
136 624 USD
|
|
|
2020-09-16 |
2020-09-14 |
VP
Vente planifiée
|
HAUSMAN DIANA
Chief Medical Officer
Dirigeant
|
40 000
-91.5%
45,00
1 800 000 USD
|
40 000
-91.5%
|
45,00
|
1 800 000 USD
|
|
|
2020-04-07 |
2020-04-03 |
A
Achat
|
Tehrani Ali
Chief Executive Officer
Administrateur exécutif
|
80
+0.1%
33,39
2 671 USD
|
80
+0.1%
|
33,39
|
2 671 USD
|
|
|
2020-04-07 |
2020-04-03 |
A
Achat
|
Tehrani Ali
Chief Executive Officer
Administrateur exécutif
|
495
+0.8%
33,39
16 528 USD
|
495
+0.8%
|
33,39
|
16 528 USD
|
|
